These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16528061)

  • 1. Treating refractory epilepsy in adults.
    Reynolds E
    BMJ; 2006 Mar; 332(7541):562-3. PubMed ID: 16528061
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic problems in complicated epilepsies of adults].
    Helmchen H
    Med Welt; 1975 Mar; 26(11):499-505. PubMed ID: 1121250
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-resistant epilepsy.
    Kwan P; Schachter SC; Brodie MJ
    N Engl J Med; 2011 Sep; 365(10):919-26. PubMed ID: 21899452
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiepileptic drug resistance and tolerance in epilepsy.
    Widdess-Walsh P; Devinsky O
    Rev Neurol Dis; 2007; 4(4):194-202. PubMed ID: 18195671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacosamide use in refractory idiopathic primary generalized epilepsy.
    Zangaladze A; Skidmore C
    Epilepsy Behav; 2012 Jan; 23(1):79-80. PubMed ID: 22197124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy.
    Summers MA; Moore JL; McAuley JW
    Ann Pharmacother; 2004 Oct; 38(10):1631-4. PubMed ID: 15328394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy in drug failure.
    Deckers CL; Knoester PD
    Seizure; 2001 Dec; 10(8):602-3. PubMed ID: 11792165
    [No Abstract]   [Full Text] [Related]  

  • 8. Addressing overtreatment in patients with refractory epilepsy at a tertiary referral centre in Brazil.
    Alexandre V; Monteiro EA; Freitas-Lima P; Pinto KD; Velasco TR; Terra VC; Pinheiro-Martins AP; Souza RM; Perucca E; Sakamoto AC
    Epileptic Disord; 2011 Mar; 13(1):56-60. PubMed ID: 21393097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory epilepsy: clinical overview.
    French JA
    Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy.
    Canevini MP; De Sarro G; Galimberti CA; Gatti G; Licchetta L; Malerba A; Muscas G; La Neve A; Striano P; Perucca E;
    Epilepsia; 2010 May; 51(5):797-804. PubMed ID: 20545754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epilepsy resistant to anticonvulsant therapy.
    Hass JA; Fenner WR
    Probl Vet Med; 1989; 1(4):596-605. PubMed ID: 2520136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiagabine: new preparation. Refractory partial epilepsy: another alternative.
    Prescrire Int; 1998 Aug; 7(36):99-101. PubMed ID: 10342943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy.
    Alexandre V; Capovilla G; Fattore C; Franco V; Gambardella A; Guerrini R; La Briola F; Ladogana M; Rosati E; Specchio LM; Striano S; Perucca E;
    Epilepsia; 2010 May; 51(5):921-5. PubMed ID: 20132292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomics of anti-epileptic drugs as adjunctive therapy for refractory epilepsy.
    Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):309-15. PubMed ID: 20545595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug resistance in epilepsy].
    Rabending G; Scherber A
    Z Arztl Fortbild (Jena); 1990; 84(15):761-6. PubMed ID: 2267815
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problem drug resistance].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2011 May; 34(5):151. PubMed ID: 21644372
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to antiepileptic drug therapy: winners and losers.
    Brodie MJ
    Epilepsia; 2005; 46 Suppl 10():31-2. PubMed ID: 16359468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monotherapy or polytherapy in the treatment of epilepsy].
    Reynolds EH; Shorvon SD; Andersen EB
    Ugeskr Laeger; 1982 Dec; 144(51):3815-8. PubMed ID: 7168078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.